Kronos Bio, Inc. Deferred Compensation Share-based Arrangements, Liability, Current
Kronos Bio, Inc. had Deferred Compensation Share-based Arrangements, Liability, Current of $0 as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent · last filed 2025-03-18
- 2024-12-31: Deferred Compensation Share-based Arrangements, Liability, Current $0.00.
- 2023-12-31: Deferred Compensation Share-based Arrangements, Liability, Current $200.00K; Deferred Compensation Share-based Arrangements, Liability, Current as first filed $209.00K.
- 2023-09-30: Deferred Compensation Share-based Arrangements, Liability, Current $350.00K.
- 2023-06-30: Deferred Compensation Share-based Arrangements, Liability, Current $490.00K.
| Period end | Deferred Compensation Share-based Arrangements, Liability, Current | Deferred Compensation Share-based Arrangements, Liability, Current as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-18 | |
| 2023-12-31 | $200.00K 10-K · filed 2025-03-18 | $209.00K 10-K · filed 2024-03-21 |
| 2023-09-30 | $350.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $490.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $708.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $891.00K 10-K · filed 2024-03-21 | |
| 2022-09-30 | $1.06M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.22M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.23M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $1.36M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $1.43M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $2.09M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.06M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $2.17M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $2.12M 10-Q · filed 2020-11-18 | |
| 2019-12-31 | $56.00K 10-K · filed 2021-03-23 |